Highlights
NASDAQ: INVA       Innoviva Inc
Last Price Today's Change   Day's Range   Trading Volume
12.13   -0.03 (0.25%)  11.98 - 12.16  123,983

Overview

 
Avg Volume (4 weeks):536,160
4 Weeks Range:10.50 - 12.51
4 Weeks Price Volatility (%):
81.09%
52 Weeks Range:10.03 - 20.54
52 Weeks Price Volatility (%):
19.98%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline.

  Be the first to like this.
 


 

2977  2556  423  3021 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FCEL 0.909+0.099 
 CHK 0.696-0.006 
 AMD 38.319+0.799 
 CSCO 44.685-3.775 
 AABA 19.630.00 
 CPE 4.30-0.16 
 SNNA 0.30+0.14 
 NIO 1.735-0.165 
 NOK 3.356-0.114 
 AMRN 21.490.00 
Partners & Brokers